(Press-News.org) Brussels and Geneva, 20th February 2013 --- Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition.
The European Association for the Study of the Liver (EASL) today unveiled its new publication The burden of liver disease in Europe: a review of available epidemiological data. Key findings in the report suggest that alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe. The report is the result of a review of 260 epidemiological studies published in the last five years in order to survey the current state of evidence on the burden of liver disease in Europe and its causes.
Speaking immediately before a launch event, hosted by Mr Stephen Hughes MEP, at the European Parliament, Prof. Mark Thursz, EASL Secretary-General, noted that "although the incidence and prevalence of liver disease in Europe is alarming, what is encouraging to see is that each of the major causes of liver disease is potentially amenable to prevention and treatment. This means we all have an opportunity to make a difference, through implementing the right policy changes. The report shows us the importance of tackling the excessive consumption of alcohol which is the leading cause of cirrhosis and primary liver cancer. The Scottish Minimum Unit Pricing of alcohol is an example of the urgent measures needed and we continue to draw attention to the importance of its implementation".
Stephen Hughes, MEP, host of the launch event at the European Parliament in Brussels, welcomed the publication of the report and took the opportunity to announce that he and a group of like-minded MEPs with an interest in Liver Disease had recently decided to create the "Friends of the Liver MEP Group". Mr Hughes, who is chair of the group, said "we hope that by creating this informal group this will enable us to raise awareness within the European Parliament of the seriousness of the liver disease epidemic and will encourage every single one of those 29 million Europeans who suffer from a chronic liver condition. They have not been forgotten. They will not be forgotten".
Prof. Markus Peck, EASL Vice-Secretary and Prof. Patrizia Burra, EASL EU Policy Councillor, both of whom were speakers at the launch event, welcomed the report's publication and Mr Hughes' announcement and said that "EASL looks forward to working with Members of the European Parliament as we take the report findings and use them to draw attention to the importance of tackling the major risk factors for liver disease and also to ensure that enough is done in order that cost-effective prevention programmes can be implemented and novel treatments to tackle liver disease and avoidable deaths in Europe are developed".
###
Contact details:
Margaret Walker, EASL Director of EU Public Affairs, margaret.walker@easloffice.eu
Mobile number: + 41 79 946 15 49
Notes to Editor:
The European Association for the Study of the Liver (EASL)
EASL is the leading liver association in Europe. EASL attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in European liver policy.
EASL believes the EU has a key role to play in raising awareness of liver disease in Europe, increasing additional funding for research, setting standards and guidelines for the prevention, diagnosis, treatment and care of liver disease across the EU and encouraging member states to make liver disease a public health and research priority.
For more information please visit www.easl.eu
About Liver Disease
Liver disease, estimated to affect 6% of the EU population (approx. 29 million people), is reported to be the EU's 5th biggest killer, accounting for at least one in six deaths. In 2004, the mortality rate for chronic liver diseases was estimated at 14.3 per 100,000 in the EU-25. This means that more than 70,000 Europeans are dying from chronic liver disease every year. Even more worrying is the fact that the EU statistics do not cover all diseases of the liver in one category, e.g. alcohol abuse related deaths and liver cancer are treated separately. Therefore, the actual rate of deaths from liver disease is certainly much higher than the statistics suggest.
About the report:
Report Title: The burden of liver disease in Europe: a review of available epidemiological data
Authors: Martin Blachier, Henri Leleu, Markus Peck-Radosavljevic, Dominique-Charles Valla and Françoise Roudot-Thoraval
Release date: 20th February 2013
ISBN No.: 978-2-8399-1176-4
A limited number of hard copies are available from EASL. The report can also be found online at http://www.easl.eu/_eu-policy/eu-literature-review
EASL publishes first comprehensive literature review on the burden of liver disease in Europe
2013-02-21
ELSE PRESS RELEASES FROM THIS DATE:
Omega-3s inhibit breast cancer tumor growth, study finds
2013-02-21
A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research from the University of Guelph.
The study, published recently in the Journal of Nutritional Biochemistry, is believed to be the first to provide unequivocal evidence that omega-3s reduce cancer risk.
"It's a significant finding," said David Ma, a professor in Guelph's Department of Human Health and Nutritional Sciences, and one of the study's authors.
"We show that lifelong exposure to omega-3s has a beneficial role in disease prevention ...
Microbubbles improve myocardial remodelling after infarction
2013-02-21
Scientists from the Bonn University Hospital successfully tested a method in mice allowing the morphological and functional sequelae of a myocardial infarction to be reduced. Tiny gas bubbles are made to oscillate within the heart via focused ultrasound - this improves microcirculation and decreases the size of the scar tissue. The results show that the mice, following myocardial infarction, have improved cardiac output as a result of this method, as compared to untreated animals. The study is now being presented in the professional journal PLOS ONE.
Every year in Germany, ...
Inhaled betadine leads to rare complication
2013-02-21
Philadelphia, Pa. (February 21, 2013) - A routine step in preparing for cleft palate surgery in a child led to an unusual—but not unprecedented—case of lung inflammation (pneumonitis), according to a report in the The Journal of Craniofacial Surgery. The journal, edited by Mutaz B. Habal, MD, FRCSC, is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The complication resulted from accidental inhalation of povidone-iodine (PI), or Betadine—an antiseptic widely used before surgery. The rare complication led to new surgical "prep" steps to reduce ...
Human heart development slower than other mammals
2013-02-21
The walls of the human heart are a disorganised jumble of tissue until relatively late in pregnancy, despite having the shape of a fully functioning heart, according to a pioneering study.
Experts from the University of Sheffield's Medical School collaborated on research to create the first comprehensive model of human heart development using observations of living foetal hearts. The results showed surprising differences from existing animal models.
Although scientists saw four clearly defined chambers in the foetal heart from the eighth week of pregnancy, they did ...
The age from when children can hop on one leg
2013-02-21
This press release is available in German. Motor development in children under five years of age can now be tested reliably: Together with colleagues from Lausanne, researchers from the University Children's Hospital Zurich and the University of Zurich have determined normative data for different exercises such as hopping or running. This enables parents and experts to gage the motor skills of young children for the first time objectively and thus identify abnormalities at an early stage.
My child still can't stand on one leg or walk down the stairs in alternating ...
Scientists unveil secrets of important natural antibiotic
2013-02-21
An international team of scientists has discovered how an important natural antibiotic called dermcidin, produced by our skin when we sweat, is a highly efficient tool to fight tuberculosis germs and other dangerous bugs.
Their results could contribute to the development of new antibiotics that control multi-resistant bacteria.
Scientists have uncovered the atomic structure of the compound, enabling them to pinpoint for the first time what makes dermcidin such an efficient weapon in the battle against dangerous bugs.
Although about 1700 types of these natural antibiotics ...
In rich and poor nations, giving makes people feel better than getting, research finds
2013-02-21
WASHINGTON - Feeling good about spending money on someone else rather than for personal benefit may be a universal response among people in both impoverished countries and rich nations, according to new research published by the American Psychological Association.
"Our findings suggest that the psychological reward experienced from helping others may be deeply ingrained in human nature, emerging in diverse cultural and economic contexts," said lead author Lara Aknin, PhD, of Simon Fraser University in Canada.
The findings provide the first empirical evidence that "the ...
Cell therapy a little more concrete thanks to VIB research
2013-02-21
Cell therapy is a promising alternative to tissue and organ transplantation for diseases that are caused by death or poor functioning of cells. Considering the ethical discussions surrounding human embryonic stem cells, a lot is expected of the so-called 'induced pluripotent stem cells' (iPS cells). However, before this technique can be applied effectively, a lot of research is required into the safety and efficacy of such iPS cells. VIB scientists associated to the UGent have developed a mouse model that can advance this research to the next step.
Lieven Haenebalcke ...
VHA plays leading role in health information technology implementation and research
2013-02-21
Philadelphia, Pa. (February 21, 2013) - The Veterans Health Administration (VHA) is aiming to become a leader in using health information technology (HIT) to change the way patients experience medical care, to decrease medical mistakes, and to improve health outcomes. A special March supplement of Medical Care highlights new research into the many and varied types of HIT projects being explored to improve the quality of patient care throughout the VHA system. Medical Care is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The special issue ...
Antibacterial protein's molecular workings revealed
2013-02-21
On the front lines of our defenses against bacteria is the protein calprotectin, which "starves" invading pathogens of metal nutrients.
Vanderbilt investigators now report new insights to the workings of calprotectin – including a detailed structural view of how it binds the metal manganese. Their findings, published online before print in the Proceedings of the National Academy of Sciences, could guide efforts to develop novel antibacterials that limit a microbe's access to metals.
The increasing resistance of bacteria to existing antibiotics poses a severe threat to ...